<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101541748</journal-id>
<journal-id journal-id-type="pubmed-jr-id">38411</journal-id>
<journal-id journal-id-type="nlm-ta">Front Biol (Beijing)</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Biol (Beijing)</journal-id>
<journal-title-group>
<journal-title>Frontiers in biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1674-7984</issn>
<issn pub-type="epub">1674-7992</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28580010</article-id>
<article-id pub-id-type="pmc">5453648</article-id>
<article-id pub-id-type="doi">10.1007/s11515-016-1438-7</article-id>
<article-id pub-id-type="manuscript">NIHMS867032</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular and genetic insights into an infantile epileptic encephalopathy â€“ CDKL5 disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Ailing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Zhaolan Joe</given-names>
</name>
<!--<email>zhaolan@mail.med.upenn.edu</email>-->
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Jiaozhou People's Hospital, Jiaozhou, Shangdong 266300, China</aff>
<aff id="A2"><label>2</label>Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA</aff>
<author-notes>
<fn fn-type="COI-statement" id="FN1">
<p><bold>Compliance with ethics guidelines</bold>: A.Z., S.H. and Z.Z. declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<!--elocation-id from pubmed: 10.1007/s11515-016-1438-7-->
<self-uri xlink:href="https://link.springer.com/article/10.1007%2Fs11515-016-1438-7"></self-uri>
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">The discovery that mutations in cyclin-dependent kinase-like 5 (<italic>CDKL5</italic>) gene are associated with infantile epileptic encephalopathy has stimulated world-wide research effort to understand the molecular and genetic basis of CDKL5 disorder. Given the large number of literature published thus far, this review aims to summarize current genetic studies, draw a consensus on proposed molecular functions, and point to gaps of knowledge in CDKL5 research.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">A systematic review process was conducted using the PubMed search engine focusing on CDKL5 studies in the recent ten years. We analyzed these publications and summarized the findings into four sections: genetic studies, CDKL5 expression patterns, molecular functions, and animal models. We also discussed challenges and future directions in each section.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">On the clinical side, CDKL5 disorder is characterized by early onset epileptic seizures, intellectual disability, and stereotypical behaviors. On the research side, a series of molecular and genetic studies in human patients, cell cultures and animal models have established the causality of CDKL5 to the infantile epileptic encephalopathy, and pointed to a key role for CDKL5 in regulating neuronal function in the brain. Mouse models of CDKL5 disorder have also been developed, and notably, manifest behavioral phenotypes, mimicking numerous clinical symptoms of CDKL5 disorder and advancing CDKL5 research to the preclinical stage.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Given what we have learned thus far, future identification of robust, quantitative, and sensitive outcome measures would be the key in animal model studies, particularly in heterozygous females. In the meantime, molecular and cellular studies of CDKL5 should focus on mechanism-based investigation and aim to uncover druggable targets that offer the potential to rescue or ameliorate CDKL5 disorder-related phenotypes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>CDKL5 disorder</kwd>
<kwd>childhood epilepsy</kwd>
<kwd>intellectual disability</kwd>
<kwd>mouse model</kwd>
<kwd>outcome measure</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>